Title
Chronic fatigue syndrome and DNA hypomethylation of the glucocorticoid receptor gene promoter 1F region : associations with hypothalamic-pituitary-adrenal axis hypofunction and childhood trauma Chronic fatigue syndrome and DNA hypomethylation of the glucocorticoid receptor gene promoter 1F region : associations with hypothalamic-pituitary-adrenal axis hypofunction and childhood trauma
Author
Faculty/Department
Faculty of Medicine and Health Sciences
Faculty of Pharmaceutical, Biomedical and Veterinary Sciences . Biomedical Sciences
Publication type
article
Publication
Roosevelt, N.Y. ,
Subject
Psychology
Human medicine
Source (journal)
Psychosomatic medicine / American Psychosomatic Society. - Roosevelt, N.Y.
Volume/pages
77(2015) :8 , p. 853-862
ISSN
0033-3174
ISI
000362707700002
Carrier
E
Target language
English (eng)
Full text (Publishers DOI)
Affiliation
University of Antwerp
Abstract
Objectives: Chronic fatigue syndrome (CFS) has been associated with hypothalamic-pituitary-adrenal axis hypofunction and enhanced glucocorticoid receptor (GR) sensitivity. In addition, childhood trauma is considered a major risk factor for the syndrome. This study examines DNA methylation of the GR gene (NR3C1) in CFS and associations with childhood sexual and physical trauma. Methods: Quantification of DNA methylation within the 1F promoter region of NR3C1 was performed in 76 female patients (46 with no/mild and 30 with moderate/severe childhood trauma) and 19 healthy controls using Sequenom EpiTYPER. Further, we examined the association of NR3C1-1F promoter methylation the low-dose (0.5 mg) dexamethasone/corticotropin-releasing factor test outcomes in a subset of the study population. Mann-Whitney U tests and Spearman correlations were used for statistical analyses. Results: Overall NR3C1-1F DNA methylation was lower in patients with CFS than in controls. After cytosine guanine dinucleotide (CpG)-specific analysis, CpG_1.5 remains significant after Bonferroni correction (adjusted p = .0014). Within the CFS group, overall methylation (? = 0.477, p = .016) and selective CpG units (CpG_1.5: ? = 0.538, p = .007; CpG_12.13: ? = 0.448, p = .025) were positively correlated with salivary cortisol after dexamethasone administration. There was no significant difference in NR3C1-1F methylation between traumatized and nontraumatized patients. Conclusions: We found evidence of NR3C1 promoter hypomethylation in female patients with CFS and the functional relevance of these differences was consistent with the hypothalamic-pituitary-adrenalaxis hypofunction hypothesis (GR hypersuppression). However, we found no evidence of an additional effect of childhood trauma on CFS via alterations in NR3C1 methylation.
Full text (open access)
https://repository.uantwerpen.be/docman/irua/00849b/558a5479.pdf
E-info
https://repository.uantwerpen.be/docman/iruaauth/0fc0b2/ef610552.pdf
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000362707700002&DestLinkType=RelatedRecords&DestApp=ALL_WOS&UsrCustomerID=ef845e08c439e550330acc77c7d2d848
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000362707700002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=ef845e08c439e550330acc77c7d2d848
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000362707700002&DestLinkType=CitingArticles&DestApp=ALL_WOS&UsrCustomerID=ef845e08c439e550330acc77c7d2d848
Handle